Skip to main content
. 2017 May 18;16(1):151–158. doi: 10.3892/mmr.2017.6607

Figure 2.

Figure 2.

Overall survival of STIM1-positive and -negative patients. The overall survival rate was significantly reduced in patients with STIM1-expressing GC tumors compared with patients with GC tumors without STIM1 expression (P=0.043). STIM1, stromal interaction molecule 1; GC, gastric cancer.